Poolbeg Pharma has signed an Option Agreement to licence MelioVac, a vaccine for melioidosis, with University College Dublin and its inventor, Associate Professor Siobhán McClean, through NovaUCD, the university’s knowledge

Infectious diseases have, over the last decade, been a relatively under-funded area of pharmaceutical research with ‘Big Pharma’ deprioritisingR&D in this space. But then an unprecedented global pandemic broughtabout devastating

Poolbeg Pharma plc (LON:POLB) is a clinical stage infectious disease pharmaceutical company, with a novel capital light clinical model which enables us to develop multiple products faster and more cost

After being practically non-existent last year, the flu is slowly coming back across the country. The University of Michigan is currently grappling with a flu outbreak and cases of the

We could be at higher risk of meeting an old foe this winter. Flu is expected to circulate more widely in the coming weeks and reach a peak in December